Table 1: Baseline patient profiles and operative characteristics.

VariableSitagliptin
( )
Placebo
( )
value

Sex, male/female, 21/827/50.255
Mean age, years62.9 ± 9.666.1 ± 10.30.222
Height (inches)67.5 ± 2.468.5 ± 3.60.241
Weight (kg)93.1 ± 20.594.2 ± 18.00.822
Cardiovascular risk factors, (%)
 History of stroke310.255
 History of CAD10
Oral antihyperglycemics
 Metformin, (%)48.1% 38.7% 0.469
 Sulfonylureas, (%)25.9%25.8%0.992
 Thiazolidinedione, (%)7.4%16.1%0.309
Preoperative A1c, %7.217.270.879
Type of procedure, (%)0.282
 CABG only82.8%84.4%
 CABG + valve6.9%0%
Mean length of pump time, minutes95.3 ± 30.988.4 ± 21.20.317
Mean length of ischemic time, minutes67.2 ± 23.265.1 ± 17.90.707